Belite Bio (BLTE) Retained Earnings (2020 - 2025)
Belite Bio's quarterly Retained Earnings came in at -$185.3 million in Q4 2025, down 72.1% year-on-year from -$664.0 million in Q4 2024, and down 72.1% quarter-over-quarter from -$107.6 million in Q4 2024.
Belite Bio has reported Retained Earnings for 6 years, with the latest figure at -$185.3 million in Q4 2025.
- For the quarter ending Q4 2025, Retained Earnings fell 72.1% year-over-year to -$185.3 million; the trailing twelve-month figure through Dec 2025 stood at -$185.3 million (down 72.1% YoY), and the FY2025 full-year result was -$185.3 million, down 72.1% from the prior year.
- Retained Earnings for Q4 2025 stood at -$185.3 million, down from -$107.6 million in the prior quarter.
- The five-year high for Retained Earnings was -$374000.0 in Q4 2023, with the low at -$185.3 million in Q4 2025.
- Average Retained Earnings over 5 years is -$64.2 million, with a median of -$27.2 million recorded in 2021.
- Year-over-year, Retained Earnings surged 98.56% in 2022 and tumbled 28682.62% in 2024.
- Tracing BLTE's Retained Earnings over 5 years: stood at -$27.2 million in 2021, then surged by 98.56% to -$392000.0 in 2022, then increased by 4.59% to -$374000.0 in 2023, then plunged by 28682.62% to -$107.6 million in 2024, then slumped by 72.1% to -$185.3 million in 2025.
- The last three Retained Earnings figures came in at -$185.3 million (Q4 2025), -$107.6 million (Q4 2024), and -$374000.0 (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -211.85 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -153.89 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -438.66 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -279.00 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 130.89 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 36.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -24.89 Mn |
| 10 | Belite Bio | 4.92 Bn | 4.45 Bn | - | -185.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -185.26 Mn |
| Sep 30, 2025 | -159.93 Mn |
| Dec 31, 2024 | -107.65 Mn |
| Dec 31, 2023 | -71.50 Mn |
| Dec 31, 2022 | -39.87 Mn |
| Dec 31, 2021 | -27.22 Mn |
| Dec 31, 2020 | -17.60 Mn |